This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2018-2023.
Location History:
- Welwyn Garden City, GB (2018 - 2020)
- Welwyn Garden, GB (2023)
Company Filing History:
Years Active: 2018-2023
Title: Ruchi Upmanyu: Innovator in Cardiovascular Therapeutics
Introduction
Ruchi Upmanyu is a notable inventor based in Welwyn Garden City, GB. She has made significant contributions to the field of cardiovascular therapeutics, holding a total of 3 patents. Her work focuses on innovative methods and compositions that aim to improve patient outcomes in cardiovascular disease.
Latest Patents
Among her latest patents, Ruchi has developed genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agents, particularly with CETP inhibitors/modulators. This invention is crucial for identifying the right patients for effective treatment, thereby enhancing therapeutic efficacy.
Career Highlights
Ruchi has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of cardiovascular health.
Collaborations
Ruchi has collaborated with esteemed colleagues such as Marie-Pierre Dube and Eric Joseph Niesor. These partnerships have further enriched her research and innovation efforts.
Conclusion
Ruchi Upmanyu's work in developing CETP inhibitors and her dedication to improving cardiovascular treatment options highlight her as a significant figure in medical innovation. Her contributions continue to pave the way for advancements in patient care and therapeutic strategies.